Starlinger, Patrick
Mayo Clinic · Medical University of Vienna
8 papers on CoChatORCID 0000-0002-4666-5337
Most cited papers
- Verified
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
Schwabl, P., Hambruch, E., Seeland, B. A., Hayden, H., Wagner, M., Garnys, L., Strobel, B., Schubert, T.-L., Riedl, F., Mitteregger, D., et al. (2017) · Journal of Hepatology
Liver Disease and TransplantationLiver physiology and pathology
Cited by 178
- Verified
E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy
Primavesi, F., Maglione, M., Cipriani, F., Denecke, T., Oberkofler, C. E., Starlinger, P., Dasari, B. V. M., Heil, J., Sgarbura, O., Søreide, K., et al. (2023) · British Journal of Surgery
Hepatocellular Carcinoma Treatment and PrognosisOrgan Transplantation Techniques and Outcomes
Cited by 97
- Verified
Current evidence on posthepatectomy liver failure: Comprehensive review
Sparrelid, E., Olthof, P. B., Dasari, B. V. M., Erdmann, J. I., Santol, J., Starlinger, P., & Gilg, S. (2022) · BJS Open
Organ Transplantation Techniques and OutcomesHepatocellular Carcinoma Treatment and Prognosis
Cited by 88
- Verified
P2X1-regulated IL-22 secretion by innate lymphoid cells is required for efficient liver regeneration
Kudira, R., Malinka, T., Kohler, A., Dosch, M., de Agüero, M. G., Melin, N., Haegele, S., Starlinger, P., Maharjan, N., Saxena, S., et al. (2016) · Hepatology
Liver physiology and pathologyAdenosine and Purinergic Signaling
Cited by 50
- Verified
PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis
Tzeng, S.-F., Yu, Y.-R., Park, J., von Renesse, J., Hsiao, H.-W., Hsu, C.-H., Garnica, J., Chen, J., Chiu, L.-T., Santol, J., et al. (2025) · Cancer Discovery
Cancer Immunotherapy and BiomarkersCancer, Lipids, and Metabolism
Cited by 49
- Verified
PNPLA3 I148M variant impairs liver X receptor signaling and cholesterol homeostasis in human hepatic stellate cells
Bruschi, F. V., Claudel, T., Tardelli, M., Starlinger, P., Marra, F., & Trauner, M. (2019) · Hepatology Communications
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 38
- Verified
The 3-60 criteria challenge established predictors of postoperative mortality and enable timely therapeutic intervention after liver resection
Gyoeri, G. P., Pereyra, D., Braunwarth, E., Ammann, M., Jonas, P., Offensperger, F., Klinglmueller, F., Baumgartner, R., Holzer, S., Gnant, M., et al. (2019) · HepatoBiliary Surgery and Nutrition
Hepatocellular Carcinoma Treatment and PrognosisInflammatory Biomarkers in Disease Prognosis
Cited by 20
- Verified
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Ammann, M., Santol, J., Pereyra, D., Kalchbrenner, T., Wuerger, T., Laengle, J., Smoot, R. L., Hulla, W., Laengle, F., & Starlinger, P. (2023) · Scientific Reports
Liver physiology and pathologyDiabetes Treatment and Management
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free